Style | Citing Format |
---|---|
MLA | Bahrami T, et al.. "The Molecular Signature of Breast Cancer Metastasis to Bone." Anti-Cancer Drugs, vol. 27, no. 9, 2016, pp. 824-831. |
APA | Bahrami T, Mokmeli S, Hossieni H, Pourpaknia R, Makani Z, Salmaninejad A, Estiar MA, Hossieni A, Farshbaf A (2016). The Molecular Signature of Breast Cancer Metastasis to Bone. Anti-Cancer Drugs, 27(9), 824-831. |
Chicago | Bahrami T, Mokmeli S, Hossieni H, Pourpaknia R, Makani Z, Salmaninejad A, Estiar MA, Hossieni A, Farshbaf A. "The Molecular Signature of Breast Cancer Metastasis to Bone." Anti-Cancer Drugs 27, no. 9 (2016): 824-831. |
Harvard | Bahrami T et al. (2016) 'The Molecular Signature of Breast Cancer Metastasis to Bone', Anti-Cancer Drugs, 27(9), pp. 824-831. |
Vancouver | Bahrami T, Mokmeli S, Hossieni H, Pourpaknia R, Makani Z, Salmaninejad A, et al.. The Molecular Signature of Breast Cancer Metastasis to Bone. Anti-Cancer Drugs. 2016;27(9):824-831. |
BibTex | @article{ author = {Bahrami T and Mokmeli S and Hossieni H and Pourpaknia R and Makani Z and Salmaninejad A and Estiar MA and Hossieni A and Farshbaf A}, title = {The Molecular Signature of Breast Cancer Metastasis to Bone}, journal = {Anti-Cancer Drugs}, volume = {27}, number = {9}, pages = {824-831}, year = {2016} } |
RIS | TY - JOUR AU - Bahrami T AU - Mokmeli S AU - Hossieni H AU - Pourpaknia R AU - Makani Z AU - Salmaninejad A AU - Estiar MA AU - Hossieni A AU - Farshbaf A TI - The Molecular Signature of Breast Cancer Metastasis to Bone JO - Anti-Cancer Drugs VL - 27 IS - 9 SP - 824 EP - 831 PY - 2016 ER - |